A.R.T. Advisors’s Cascadian Therapeutics, Inc. CASC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-10,761
| Closed | -$44K | – | 1873 |
|
|
2017
Q3 | $44K | Sell |
10,761
-758
| -7% | -$3.1K | ﹤0.01% | 1264 |
|
|
2017
Q2 | $42K | Sell |
11,519
-22,500
| -66% | -$82K | ﹤0.01% | 1318 |
|
|
2017
Q1 | $140K | Buy |
+34,019
| New | +$140K | 0.01% | 1230 |
|
|
2016
Q3 | – | Sell |
-37,712
| Closed | -$213K | – | 1469 |
|
|
2016
Q2 | $213K | Buy |
37,712
+22,413
| +146% | +$127K | 0.01% | 1086 |
|
|
2016
Q1 | $116K | Sell |
15,299
-49,633
| -76% | -$376K | 0.01% | 1240 |
|
|
2015
Q4 | $864K | Buy |
+64,932
| New | +$864K | 0.04% | 639 |
|
|
2014
Q3 | – | Sell |
-13,229
| Closed | -$257K | – | 1664 |
|
|
2014
Q2 | $257K | Buy |
13,229
+4,955
| +60% | +$96.3K | 0.01% | 1038 |
|
|
2014
Q1 | $148K | Sell |
8,274
-2,303
| -22% | -$41.2K | 0.01% | 1197 |
|
|
2013
Q4 | $111K | Hold |
10,577
| – | – | 0.01% | 1184 |
|
|
2013
Q3 | $130K | Buy |
10,577
+8,034
| +316% | +$98.7K | 0.01% | 1186 |
|
|
2013
Q2 | $23K | Buy |
+2,543
| New | +$23K | ﹤0.01% | 1298 |
|